Renal Cancers Completed Phase 2 Trials for Semaxanib (DB06436)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00006384SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney CancerTreatment